202 related articles for article (PubMed ID: 21447726)
1. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a.
Lin C; Wu Z; Lin X; Yu C; Shi T; Zeng Y; Wang X; Li J; Song L
Clin Cancer Res; 2011 May; 17(10):3089-99. PubMed ID: 21447726
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
Zeng Z; Lin H; Zhao X; Liu G; Wang X; Xu R; Chen K; Li J; Song L
Clin Cancer Res; 2012 Aug; 18(15):4059-69. PubMed ID: 22675169
[TBL] [Abstract][Full Text] [Related]
3. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
[TBL] [Abstract][Full Text] [Related]
4. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR
J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256
[TBL] [Abstract][Full Text] [Related]
5. Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
Wang X; Lin C; Zhao X; Liu A; Zhu J; Li X; Song L
Mol Cancer; 2014 May; 13():106. PubMed ID: 24886245
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of flotillin-2 impairs the proliferation of breast cancer cells through modulation of Akt/FOXO signaling.
Xie G; Li J; Chen J; Tang X; Wu S; Liao C
Oncol Rep; 2015 May; 33(5):2285-90. PubMed ID: 25738752
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
[TBL] [Abstract][Full Text] [Related]
8. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival.
Zhang Y; Li J; Song Y; Chen F; Pei Y; Yao F
Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
10. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
[TBL] [Abstract][Full Text] [Related]
11. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.
Xu X; Wu J; Li S; Hu Z; Xu X; Zhu Y; Liang Z; Wang X; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
Mol Cancer; 2014 May; 13():109. PubMed ID: 24886554
[TBL] [Abstract][Full Text] [Related]
13. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
Fang L; Wang H; Zhou L; Yu D
Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
[TBL] [Abstract][Full Text] [Related]
14. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of flotillin-1 is involved in proliferation and recurrence of bladder transitional cell carcinoma.
Guan Y; Song H; Zhang G; Ai X
Oncol Rep; 2014 Aug; 32(2):748-54. PubMed ID: 24890092
[TBL] [Abstract][Full Text] [Related]
16. The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway.
Yu C; Zhang Z; Liao W; Zhao X; Liu L; Wu Y; Liu Z; Li Y; Zhong Y; Chen K; Li J; Zhou F; Song L
Carcinogenesis; 2012 Mar; 33(3):678-86. PubMed ID: 22223847
[TBL] [Abstract][Full Text] [Related]
17. Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells.
Song L; Wang L; Li Y; Xiong H; Wu J; Li J; Li M
J Pathol; 2010 Nov; 222(3):227-37. PubMed ID: 20662004
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.
Wolfe AR; Debeb BG; Lacerda L; Larson R; Bambhroliya A; Huang X; Bertucci F; Finetti P; Birnbaum D; Van Laere S; Diagaradjan P; Ruffell B; Trenton NJ; Chu K; Hittelman W; Diehl M; Levental I; Ueno NT; Woodward WA
Breast Cancer Res Treat; 2015 Dec; 154(3):495-508. PubMed ID: 26590814
[TBL] [Abstract][Full Text] [Related]
19. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a.
Lin H; Dai T; Xiong H; Zhao X; Chen X; Yu C; Li J; Wang X; Song L
PLoS One; 2010 Dec; 5(12):e15797. PubMed ID: 21203424
[TBL] [Abstract][Full Text] [Related]
20. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
